Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
Santos A, Desgranges F, Jovanovic M, Anichini A, Kritikos A, Dunet V, Brouland JP, Théaudin M, Pot C, Du Pasquier R, Pantazou V. Santos A, et al. Among authors: anichini a. Can J Neurol Sci. 2022 May;49(3):445-451. doi: 10.1017/cjn.2021.138. Epub 2021 Jun 21. Can J Neurol Sci. 2022. PMID: 34165067
[Recent Advances in Neurology].
Anichini A, Salvioni Chiabotti P, Bally J, Castro Jimenez M, Démonet JF, Di Virgilio G, Hirt L, Hottinger A, Kuntzer T, Michel P, Novy J, Pot Kreis C, Rossetti AO, Rouaud O, Théaudin M, Du Pasquier R. Anichini A, et al. Rev Med Suisse. 2021 Jan 27;17(723):196-200. Rev Med Suisse. 2021. PMID: 33507660 French.
Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.
Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, Cerutti-Sola J, Rossetti AO, Du Pasquier R. Bernard-Valnet R, et al. Among authors: anichini a. Eur J Neurol. 2020 Sep;27(9):e43-e44. doi: 10.1111/ene.14298. Epub 2020 May 30. Eur J Neurol. 2020. PMID: 32383343 Free PMC article. No abstract available.
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
Bernard-Valnet R, Perriot S, Canales M, Pizzarotti B, Caranzano L, Castro-Jiménez M, Epiney JB, Vijiala S, Salvioni-Chiabotti P, Anichini A, Salerno A, Jaton K, Vaucher J, Perreau M, Greub G, Pantaleo G, Du Pasquier RA. Bernard-Valnet R, et al. Among authors: anichini a. Neurol Neuroimmunol Neuroinflamm. 2021 Jun 16;8(5):e1029. doi: 10.1212/NXI.0000000000001029. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34135107 Free PMC article.
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Muraro E, Montico B, Lum B, Colizzi F, Giurato G, Salvati A, Guerrieri R, Rizzo A, Comaro E, Canzonieri V, Anichini A, Del Vecchio M, Mortarini R, Milione M, Weisz A, Pizzichetta MA, Simpson F, Dolcetti R, Fratta E, Sigalotti L. Muraro E, et al. Among authors: anichini a. Front Immunol. 2024 Mar 6;15:1336566. doi: 10.3389/fimmu.2024.1336566. eCollection 2024. Front Immunol. 2024. PMID: 38510242 Free PMC article.
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Lofiego MF, Piazzini F, Caruso FP, Marzani F, Solmonese L, Bello E, Celesti F, Costa MC, Noviello T, Mortarini R, Anichini A, Ceccarelli M, Coral S, Di Giacomo AM, Maio M, Covre A; EPigenetic Immune-oncology Consortium Airc (EPICA) investigators. Lofiego MF, et al. Among authors: anichini a. J Transl Med. 2024 Mar 1;22(1):223. doi: 10.1186/s12967-024-05040-x. J Transl Med. 2024. PMID: 38429759 Free PMC article.
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Noviello TMR, Di Giacomo AM, Caruso FP, Covre A, Mortarini R, Scala G, Costa MC, Coral S, Fridman WH, Sautès-Fridman C, Brich S, Pruneri G, Simonetti E, Lofiego MF, Tufano R, Bedognetti D, Anichini A, Maio M, Ceccarelli M. Noviello TMR, et al. Among authors: anichini a. Nat Commun. 2023 Sep 22;14(1):5914. doi: 10.1038/s41467-023-40994-4. Nat Commun. 2023. PMID: 37739939 Free PMC article. Clinical Trial.
Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma.
Vandoni G, D'Amico F, Fabbrini M, Mariani L, Sieri S, Casirati A, Di Guardo L, Del Vecchio M, Anichini A, Mortarini R, Sgambelluri F, Celano G, Serale N, De Angelis M, Brigidi P, Gavazzi C, Turroni S. Vandoni G, et al. Among authors: anichini a. Int J Mol Sci. 2023 Jul 18;24(14):11611. doi: 10.3390/ijms241411611. Int J Mol Sci. 2023. PMID: 37511376 Free PMC article.
196 results